IL-4 inhibits the expression of high affinity IL-2 receptors on monoclonal human B cells

J Immunol. 1990 Aug 15;145(4):1152-8.

Abstract

In the presence of anti-mu antibodies (anti-microAb), monoclonal B lymphocytes from patients suffering from B type chronic lymphocytic leukemia (B-CLL) can respond to IL-2. In contrast to the effect it exerts on normal B cells, IL-4 does not promote DNA synthesis by B-CLL lymphocytes. Rather this interleukin inhibits the response to IL-2 in all patients' cells that responded to this interleukin. We thus examined whether IL-4 would modulate the number and/or the affinity of IL-2 receptors. A 3-day activation of cells by anti-microAb induced a few hundred high affinity IL-2 receptors (HA-IL-2R) on B-CLL cell surface, as determined by Scatchard analysis. Treatment of cells with IL-4 caused a marked decrease in the number of HA-IL-2R without interfering with the binding ability of IL-2. In contrast with this profound suppressive effect, IL-4 did not down-regulate the expression of each chain, alpha and beta (p55 and p75, respectively), of the HA-IL-2R heterodimer. In fact, the expression of alpha and beta induced by anti-microAb was enhanced by IL-4. Altogether, IL-4 exerts a critical influence on the function and the configuration of HA-IL-2R without inhibiting the expression of two subunits, alpha and beta.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocytes / analysis
  • Dose-Response Relationship, Drug
  • Humans
  • Interleukin-2 / metabolism
  • Interleukin-4 / pharmacology*
  • Kinetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / metabolism
  • Receptors, Interleukin-2 / analysis*

Substances

  • Interleukin-2
  • Receptors, Interleukin-2
  • Interleukin-4